These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31980082)

  • 61. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alport syndrome in a Kazakh family: a case study.
    Zholdybayeva EV; Rakhimova SE; Baikara BT; Nigmatullina NB; Mustapayeva NM; Momynaliev KT
    J Genet; 2014 Dec; 93(3):855-8. PubMed ID: 25572247
    [No Abstract]   [Full Text] [Related]  

  • 63. Bull's eye and pigment maculopathy are further retinal manifestations of an abnormal Bruch's membrane in Alport syndrome.
    Savige J; Wang Y; Crawford A; Smith J; Symons A; Mack H; Nicholls K; Wilson D; Colville D
    Ophthalmic Genet; 2017; 38(3):238-244. PubMed ID: 27485810
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
    Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
    Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel human pathological mutations. Gene symbol: COL4A5. Disease: Alport syndrome.
    Ellison J
    Hum Genet; 2009 Aug; 126(2):331. PubMed ID: 19693995
    [No Abstract]   [Full Text] [Related]  

  • 66. Alport syndrome diagnosed by immunofluorescence using a new monoclonal antibody.
    Kiyatake I; Tomino Y; Shirato I; Nakayama S; Koide H
    Intern Med; 1993 Jan; 32(1):26-30. PubMed ID: 8495040
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transfer of the alpha 5(IV) collagen chain gene to smooth muscle restores in vivo expression of the alpha 6(IV) collagen chain in a canine model of Alport syndrome.
    Harvey SJ; Zheng K; Jefferson B; Moak P; Sado Y; Naito I; Ninomiya Y; Jacobs R; Thorner PS
    Am J Pathol; 2003 Mar; 162(3):873-85. PubMed ID: 12598321
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Familial hematurias: what we know and what we don't.
    Kashtan CE
    Pediatr Nephrol; 2005 Aug; 20(8):1027-35. PubMed ID: 15856317
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.
    Helle OMB; Pedersen TH; Ousager LB; Thomassen M; Hertz JM
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1452. PubMed ID: 32812400
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers.
    Rosado C; Bueno E; Fraile P; García-Cosmes P; González-Sarmiento R
    Eur J Med Genet; 2015 Jan; 58(1):35-8. PubMed ID: 25450602
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion.
    Kuwazuru J; Suico MA; Omachi K; Kojima H; Kamura M; Kaseda S; Kawahara T; Hitora Y; Kato H; Tsukamoto S; Wada M; Asano T; Kotani S; Nakajima M; Misumi S; Sannomiya Y; Horizono J; Koyama Y; Owaki A; Shuto T; Kai H
    Kidney360; 2023 Jul; 4(7):909-917. PubMed ID: 37143203
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.
    Beicht S; Strobl-Wildemann G; Rath S; Wachter O; Alberer M; Kaminsky E; Weber LT; Hinrichsen T; Klein HG; Hoefele J
    Gene; 2013 Sep; 526(2):474-7. PubMed ID: 23732293
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Prenatal diagnosis and genetic counseling of X-linked Alport syndrome in China].
    Zhang HW; Ding J; Wang F; Yang HX
    Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):484-9. PubMed ID: 17953801
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Trypsin digestion on paraffin sections is a useful tool for diagnosis of alport syndrome.
    Jiang YS; Ehara T
    Ultrastruct Pathol; 2010 Aug; 34(4):199-206. PubMed ID: 20594039
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bilateral giant macular holes: A rare manifestation of Alport syndrome.
    Raimundo M; Fonseca C; Silva R; Figueira J
    Eur J Ophthalmol; 2019 Jan; 29(1):NP13-NP16. PubMed ID: 29873249
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MLPA and cDNA analysis improves COL4A5 mutation detection in X-linked Alport syndrome.
    Hertz JM; Juncker I; Marcussen N
    Clin Genet; 2008 Dec; 74(6):522-30. PubMed ID: 18616531
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
    Thielen BK; Barker DF; Nelson RD; Zhou J; Kren SM; Segal Y
    Hum Mutat; 2003 Nov; 22(5):419. PubMed ID: 14517961
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
    Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
    J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The 2019 and 2021 International Workshops on Alport Syndrome.
    Daga S; Ding J; Deltas C; Savige J; Lipska-Ziętkiewicz BS; Hoefele J; Flinter F; Gale DP; Aksenova M; Kai H; Perin L; Barua M; Torra R; Miner JH; Massella L; Ljubanović DG; Lennon R; Weinstock AB; Knebelmann B; Cerkauskaite A; Gear S; Gross O; Turner AN; Baldassarri M; Pinto AM; Renieri A
    Eur J Hum Genet; 2022 May; 30(5):507-516. PubMed ID: 35260866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.